IHS Chemical Week
FINE CHEMICALS/BIOTECH

Mitsubishi Gas Chemical subsidiary and Catalent sign deal for biosimilars

12:28 AM MST | January 26, 2015 | Deepti Ramesh

MGC Pharma (Tokyo), a wholly owned subsidiary of Mitsubishi Gas Chemical (MGC), and Catalent Pharma Solutions (Somerset, NJ), a leading contract manufacturer of pharmaceuticals, have entered into an agreement to jointly research, develop, and produce...


Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com
MORE FINE CHEMICALS/BIOTECH

FDA issues import alert against Ipca API plant

FDA, on 22 January, issued an import alert for an active pharmaceutical ingredient (API) manufacturing facility of Ipca Laboratories (Mumbai), located at Ratlam, India. An import alert allows FDA to detain, without physically examining, products that either...

Bayer CropScience's new Sivanto insecticide receives US registration

Bayer CropScience says it has has received registration for its new insecticide Sivanto from EPA. Sivanto, which was developed to control devastating sucking pests on fruits and vegetables, as well as most broadacre crops, will be available for the 2015...

Cellulosic sugar company raises $16 million

Cellulosic sugar producer Edeniq (Visalia, CA) today announced it has raised more than $16 million in equity.  The equity investment was led by I2BF Global Ventures, an existing investor; Draper Fisher Jurvetson, Angeleno Group, Flint Hills Resources...

Pharma/fine chemicals roundup—20 January 2015

AMRI receives NIH contract for drug development and manufacturing services Albany Molecular Research Inc. (AMRI; Albany) says that it has received a 10-year federal contract award from the National Institutes of Health (NIH; Bethesda, MD) for drug development...

AMRI receives NIH contract for drug development and manufacturing services

Albany Molecular Research Inc. (AMRI; Albany) says that it has received a 10-year federal contract award from the National Institutes of Health (NIH; Bethesda, MD) for drug development and manufacturing services. The NIH/National Institute of Neurological...

Shire to acquire NPS Pharma for $5.2 billion building leading biotech position

Shire (Dublin) and NPS Pharmaceuticals (Bedminster, NJ) today announced that they have entered into an agreement for Shire to acquire all the outstanding shares of NPS Pharma for $46.00/share in cash, for a total of approximately $5.2 billion. The price...

New law widens opportunity for cultivation of GM crops in Europe

The European Union will devolve to its 28 individual member states the power to authorize the cultivation of genetically modified (GM) crops, allowing national governments to either approve new GM crops or ban them on nonscientific grounds. The move is likely...

Hovione appoints head of R&D

Active pharmaceutical ingredients (APIs) producer Hovione (Loures, Portugal) says that it has appointed Filipe Gaspar as v.p./R&D. Gaspar will lead the teams based at Lisbon and New Jersey that serve the drug development projects of Hovione’s...

Pharma/fine chemicals roundup—13 January 2015

AMRI to acquire Aptuit’s drug product development and aseptic clinical manufacturing businesses Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has acquired Aptuit’s (Greenwich, CT) Glasgow, UK, business and has entered into a...

Fine Chemicals/Biotech Archives »











 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa